OnKure Therapeutics Inc. Class A (OKUR) Live Share Price, Invest From India

OnKure Therapeutics Inc. Class A Stock Performance

as on August 8, 2026 at 2:16 pm IST

Day's Low
Day's High
$4.01
Day's Price Range
$4.26
$4.14
3.14%
Downside
2.90%
Upside
52 Week's Low
52 Week's High
$1.91
52-Week Price Range
$5.38
$4.14
53.86%
Downside
29.95%
Upside

OnKure Therapeutics Inc. Class A share price movements today

Previous Close: $4.15
Open: $4.20
Volume: 148.5K
Day's Low - High: $4.01 - $4.26
52 Week Low - High: $1.91 - $5.38

OnKure Therapeutics Inc. Class A Historical Returns

1 Month Return: -6.95 %
3 Month Return: + 6.14 %
1 Year Return: + 103.43 %
3 Year Return: 0 %
5 Year Return: 0 %

OnKure Therapeutics Inc. Class A Stock Fundamentals & Key Indicators

Check OnKure Therapeutics Inc. Class A market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$168.5M

EPS (TTM)

-2.3625

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-42.73%

OnKure Therapeutics Inc. Class A vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of OnKure Therapeutics Inc. Class A with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
OnKure Therapeutics Inc. Class A	NA	$168.5M	NA	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$41.9B	624.31%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$122.9B	141.53%	27.85	35.00%	NA
Regeneron Pharmaceuticals Inc.	BUY	$79.1B	25.76%	18.83	27.87%	0.48%

Stock Returns calculator for OnKure Therapeutics Inc. Class A Stock including INR - Dollar returns

The OnKure Therapeutics Inc. Class A stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

OnKure Therapeutics Inc. Class A investment value today

Current value as on today

₹2,20,397

Returns

₹1,20,397

(+120.4%)

Returns from OnKure Therapeutics Inc. Class A Stock

₹1,02,941 (+102.94%)

Dollar Impact

₹17,456 (+17.46%)

Indian Investors' Interest in OnKure Therapeutics Inc. Class A Stock

Search interest for OnKure Therapeutics Inc. Class A Stock has decreased by -53% in the last 30 days, reflecting a downward trend in search activity.

Time period: July 10, 2026 to August 9, 2026

Change:-53% versus previous 30 day period

OnKure Therapeutics Inc. Class A Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	-	0	0
Operating Income	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-
Net Income	-9	-14	-3	-35	-15	-15	-14	-13	-15
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

OnKure Therapeutics Inc. Class A Annual Profit & Loss

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-
Gross Profit	0	0	0	0
Operating Income	-	-	-	-
EBITDA	-	-	-	-
Interest Expense	-	-	-	-
Depreciation	-	-	-	-
Income Before Tax	-	-	-	-
Income Tax Expense	-	-	-	-
Net Income	-29	-35	-52	-59
Net Profit Margin	0.00%	0.00%	0.00%	0.00%

Global Institutional Holdings in OnKure Therapeutics Inc. Class A

Funds	Holdings
StepStone Group LLC	6.59%
ADAR1 Capital Management LLC	6.03%
CANTOR FITZGERALD, L. P.	0.24%
Highbridge Capital Management, LLC	1.32%
Bvf Inc	4.9%

See all

Insights on OnKure Therapeutics Inc. Class A

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 6 months, OKUR stock has moved up by 62.1%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 567.8% return, outperforming this stock by 661.6%
NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 465.2% return, outperforming this stock by 361.8%

About OnKure Therapeutics Inc. Class A

OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3-kinase alpha (PI3Ka) harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company was founded in 2011 and is headquartered in Boulder, Colorado.

Organisation	OnKure Therapeutics Inc. Class A
Headquarters	6707 Winchester Circle, Boulder, CO, United States, 80301
Industry	Biotechnology
CEO	Dr. Nicholas A. Saccomano Ph.D.
E-voting on shares	Click here to vote

Key Management of OnKure Therapeutics Inc. Class A

Name	Title
Dr. Kevin S. Litwiler Ph.D.	Senior Vice President of DMPK & Clinical Pharmacology
Dr. Nicholas A. Saccomano Ph.D.	President, CEO & Director
Mr. Jason A. Leverone CPA	Chief Financial Officer
Dr. Samuel Agresta M.D., M.P.H.	Chief Medical Officer
Mr. Rogan P. Nunn J.D.	General Counsel & Secretary
Ms. Roberta Alton	Senior Vice President of Clinical Operations
Dr. Isaac Manke Ph.D.	Senior VP of Business Development & Director
Dr. Dylan Hartley Ph.D.	Chief Scientific Officer
Dr. James Blake Ph.D.	Senior Vice President of Computational Drug Discovery
Dr. Mark L. Boys Ph.D.	Senior Vice President of Discovery Chemistry

FAQs

What is OnKure Therapeutics Inc. Class A share price today?

OnKure Therapeutics Inc. Class A share price today is $4.14 as on August 8, 2026 at 8:46 am IST at the close of the market. OnKure Therapeutics Inc. Class A share today touched a day high of $4.26 and a low of $4.01.

What is the 52 week high and 52 week low for OnKure Therapeutics Inc. Class A share?

OnKure Therapeutics Inc. Class A share touched a 52 week high of $5.38 on January 1, 1970 and a 52 week low of $1.91 on January 1, 1970. OnKure Therapeutics Inc. Class A stock price today i.e. August 8, 2026 at 8:46 am IST is closed at $4.14,which is 23.05% down from its 52 week high and 116.75% up from its 52 week low.

What is OnKure Therapeutics Inc. Class A's market capitalisation today?

OnKure Therapeutics Inc. Class A market capitalisation is $0.00T as on August 8, 2026 at 8:46 am IST.

How to invest in OnKure Therapeutics Inc. Class A Stock (OKUR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for OnKure Therapeutics Inc. Class A on INDmoney app. Click on Buy button. You can invest as low as $1.5 in OnKure Therapeutics Inc. Class A Shares that will get you 0.3623 shares as per OnKure Therapeutics Inc. Class A share price of $4.14 per share as on August 8, 2026 at 8:46 am IST.

What is the minimum amount required to buy OnKure Therapeutics Inc. Class A Stock (OKUR) from India?

Indian investors can start investing in OnKure Therapeutics Inc. Class A (OKUR) shares with as little as ₹95.2 or $1 (as of August 9, 2026 at 10:00 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹952.00 in OnKure Therapeutics Inc. Class A stock (as per the Rupee-Dollar exchange rate as on August 9, 2026 at 10:00 pm IST). Based on OnKure Therapeutics Inc. Class A share’s latest price of $4.14 as on August 8, 2026 at 8:46 am IST, you will get 2.4155 shares of OnKure Therapeutics Inc. Class A. Learn more about fractional shares .